Your browser doesn't support javascript.
loading
Assessment of Outcomes After Stopping Tyrosine Kinase Inhibitors Among Patients With Chronic Myeloid Leukemia: A Nonrandomized Clinical Trial.
Atallah, Ehab; Schiffer, Charles A; Radich, Jerald P; Weinfurt, Kevin P; Zhang, Mei-Jie; Pinilla-Ibarz, Javier; Kota, Vamsi; Larson, Richard A; Moore, Joseph O; Mauro, Michael J; Deininger, Michael W N; Thompson, James E; Oehler, Vivian G; Wadleigh, Martha; Shah, Neil P; Ritchie, Ellen K; Silver, Richard T; Cortes, Jorge; Lin, Li; Visotcky, Alexis; Baim, Arielle; Harrell, Jill; Helton, Bret; Horowitz, Mary; Flynn, Kathryn E.
Afiliação
  • Atallah E; Department of Medicine, Medical College of Wisconsin, Milwaukee.
  • Schiffer CA; Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, Michigan.
  • Radich JP; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Weinfurt KP; Department of Population Health Sciences, Duke University School of Medicine, Durham, North Carolina.
  • Zhang MJ; Division of Biostatistics, Medical College of Wisconsin, Milwaukee.
  • Pinilla-Ibarz J; Department of Malignant Hematology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida.
  • Kota V; Georgia Cancer Center, Augusta University Medical Center, Augusta.
  • Larson RA; Department of Medicine and Comprehensive Cancer Center, University of Chicago, Chicago, Illinois.
  • Moore JO; Duke Cancer Institute, Durham, North Carolina.
  • Mauro MJ; Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Deininger MWN; Division of Hematology and Hematologic Malignancies, Huntsman Cancer Institute, The University of Utah, Salt Lake City.
  • Thompson JE; Department of Medicine, Roswell Park Cancer Institute, Buffalo, New York.
  • Oehler VG; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Wadleigh M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Shah NP; Department of Medicine, University of California at San Francisco, San Francisco.
  • Ritchie EK; Division of Medicine, Department of Medical Oncology and Hematology, Weill Medical College of Cornell University, New York, New York.
  • Silver RT; Division of Medicine, Department of Medical Oncology and Hematology, Weill Medical College of Cornell University, New York, New York.
  • Cortes J; Georgia Cancer Center, Augusta University Medical Center, Augusta.
  • Lin L; Department of Population Health Sciences, Duke University School of Medicine, Durham, North Carolina.
  • Visotcky A; Division of Biostatistics, Medical College of Wisconsin, Milwaukee.
  • Baim A; Department of Medicine, Medical College of Wisconsin, Milwaukee.
  • Harrell J; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Helton B; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Horowitz M; Department of Medicine, Medical College of Wisconsin, Milwaukee.
  • Flynn KE; Department of Medicine, Medical College of Wisconsin, Milwaukee.
JAMA Oncol ; 7(1): 42-50, 2021 Jan 01.
Article em En | MEDLINE | ID: mdl-33180106
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Temas: ECOS / Aspectos_gerais Bases de dados: MEDLINE Assunto principal: Leucemia Mielogênica Crônica BCR-ABL Positiva / Proteínas de Fusão bcr-abl Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Aspecto: Patient_preference Limite: Adult / Female / Humans / Middle aged Idioma: En Revista: JAMA Oncol Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Temas: ECOS / Aspectos_gerais Bases de dados: MEDLINE Assunto principal: Leucemia Mielogênica Crônica BCR-ABL Positiva / Proteínas de Fusão bcr-abl Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Aspecto: Patient_preference Limite: Adult / Female / Humans / Middle aged Idioma: En Revista: JAMA Oncol Ano de publicação: 2021 Tipo de documento: Article